kabutan

TRANSGENIC GROUP INC.(2342) Summary

2342
TSE Standard
TRANSGENIC GROUP INC.
263
JPY
+1
(+0.38%)
Apr 28, 3:30 pm JST
1.65
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
260.5
Apr 28, 11:30 pm JST
Summary Chart Historical News Financial Result
PER
109.5
PBR
0.89
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
265 JPY 1.66 USD
Previous Close Apr 27
262 JPY 1.64 USD
High Apr 28, 9:13 am
266 JPY 1.66 USD
Low Apr 28, 12:30 pm
258 JPY 1.61 USD
Volume
139,500
Trading Value
0.04B JPY 0.23M USD
VWAP
260.85 JPY 1.64 USD
Minimum Trading Value
26,300 JPY 165 USD
Market Cap
4.47B JPY 0.03B USD
Number of Trades
213
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly High
1-Year Average
698
1-Year High Dec 4, 2025
20,104
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 1,437,100
Apr 17, 2026 0 1,149,700
Apr 10, 2026 0 1,107,100
Apr 3, 2026 0 1,119,900
Mar 27, 2026 0 1,091,800
Company Profile
TRANSGENIC GROUP INC. is a biotech venture supporting drug discovery research. The company specializes in genetic analysis using mice and is expanding through succession-based M&A.
Sector
Services
TRANSGENIC GROUP INC. operates two main business segments: drug discovery support and investment/consulting. In the drug discovery support segment, the company offers services such as genetically modified mouse production, antibody production, glycan analysis and synthesis, preclinical trials, and clinical trial outsourcing. The investment and consulting segment focuses on promoting new businesses through M&A and supporting business succession and revitalization. This segment includes various activities such as the sale of electrical products, import and sale of Western tableware, development and sale of information and communication equipment, import and sale of auxiliary materials for multi-layered glass and glass processing equipment, and import and sale of printer toners.